|Bid||86.230 x 800|
|Ask||86.560 x 800|
|Day's Range||79.610 - 86.140|
|52 Week Range||52.170 - 109.050|
|Beta (3Y Monthly)||1.68|
|PE Ratio (TTM)||82.47|
|Earnings Date||Nov 28, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||105.50|
Medtronic's (MDT) resolve to take over the Israel-based robotic surgical guidance systems company, Mazor Robotics, adheres to its goal to grow in the sphere of robotics spine surgery.
Hill Rom (HRC) sets sights on product innovation. In patient support systems, the company unveils Hill-Rom Envella Air Fluidized Therapy Bed.
Haemonetics (HAE) sees encouraging growth at the North America Plasma revenues on strong disposables along with growing software revenues.
Twitter, Marriott Vacations, Veeva, Attunity and Apptio highlighted as Zacks Bull and Bear of the Day
In a matter of just a few years, "the Cloud" has evolved from a budding new tech feature to one of the main factors driving growth in the technology sector. We've highlighted three stocks that are showing strong cloud-related activity and strong fundamental metrics. Check out these three cloud stocks to buy right now!
An increasing number of data, technology, and service providers are partnering with Veeva Systems (VEEV) to empower life sciences organizations with faster, accurate customer data. More companies are making the switch to Veeva OpenData to improve field productivity and drive better customer engagement. There are now more than 100 Veeva OpenData partners available to help biopharma and pharmaceutical companies extend the value of quality customer data across their organizations.
91% of CROs taking steps to unify clinical operations for better visibility and improved study execution
Veeva Systems (VEEV), a provider of quality and regulatory cloud software for the consumer goods, cosmetics, chemical, and life sciences industries, today announced Laboratoires FILL-MED, a Filorga Group company, and Novacap are adopting Veeva QualityOne to modernize quality management. QualityOne allows organizations to manage quality processes, document control, and data in a single application. Leading chemical and cosmetics companies can now implement agile quality processes to ensure ongoing compliance and improve collaboration.
Shares of the life sciences industry-focused cloud solutions provider had a tough month last month. Here's what investors should know.
Veeva Systems (VEEV) closed at $96.63 in the latest trading session, marking a -0.54% move from the prior day.
Veeva Systems Inc. , a leading industry cloud provider for life sciences, will announce financial results for its fiscal third quarter which ended October 31, 2018 after market close on November 28, 2018.
Veeva Systems (VEEV) today announced that Menarini, an Italian-based biopharmaceutical company, selected Veeva CRM to improve commercial execution throughout its over-the-counter (OTC) business. Veeva CRM will provide Menarini field teams with real-time customer insights to drive more effective and efficient engagement with pharmacies. “We wanted to standardize on a single CRM solution that could scale and support Menarini’s rapid growth,” said Maurizio Luongo, corporate OTC business director at Menarini.
There’s no denying that the tech sector has been one of the major drivers of overall market performance since the end of the recession. Amazon, GOOG and FB all missed on revenue growth and gave some mixed guidance figures for the future. As expected, investors have dumped the FANGs in a big way.
In the latest trading session, Veeva Systems (VEEV) closed at $92.45, marking a +1.2% move from the previous day.
Veeva Systems Inc (NYSE:VEEV), a large-cap worth US$12.1b, comes to mind for investors seeking a strong and reliable stock investment. Most investors favour these big stocks due to their strong Read More...
Here's a look at some of the Bay Area tech companies that Wall Street analysts think might be takeover targets in the wake of IBM's planned $34 billion purchase of Red Hat.